Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG (2008). „Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome”. The American Journal of Gastroenterology. 103 (10): 2562—9. PMID18775020. doi:10.1111/j.1572-0241.2008.02115.x.
nih.gov
ncbi.nlm.nih.gov
Jerning E, Svantesson GT, Mohell N (1998). „Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.”. Eur J Pharmacol. 360 (2-3): 219—225. PMID9851589. doi:10.1016/S0014-2999(98)00667-0.
Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG (2008). „Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome”. The American Journal of Gastroenterology. 103 (10): 2562—9. PMID18775020. doi:10.1111/j.1572-0241.2008.02115.x.